» Articles » PMID: 10379743

The Value of a Second Transurethral Resection in Evaluating Patients with Bladder Tumors

Overview
Journal J Urol
Publisher Wolters Kluwer
Specialty Urology
Date 1999 Jun 24
PMID 10379743
Citations 88
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The role of a routine second transurethral resection in evaluating and managing bladder tumors is defined.

Materials And Methods: From January to October 1998, 150 patients with new or recurrent bladder tumors underwent repeat transurethral resection within 2 to 6 weeks after the initial resection, and the results, including the presence of residual tumor and tumor stage, were compared.

Results: Of the 150 cases 36 (24%) had no and 114 (76%) had residual tumor on repeat transurethral resection. Of 96 cases with superficial (Ta, Tis, T1) bladder tumors 72 (75%) had residual noninvasive tumor and 28 (29%) were up staged to invasive tumor. Among 54 patients with a muscle invasive tumor 12 (22%) had no residual tumor on repeat transurethral resection. Results of the second resection changed tumor treatment in 50 patients (33%).

Conclusions: Many patients with bladder tumors have tumor present after an initial trans-urethral resection. Routine repeat resection is advised to control noninvasive tumors and to detect residual tumor invasion.

Citing Articles

Feasibility, Safety, and Patient Satisfaction of Transurethral Bladder Tumor Resection in an Outpatient Setting.

Strahl L, Borgmann H, Struck J, Salem J, Kuru T Cancer Rep (Hoboken). 2025; 8(3):e70120.

PMID: 40071469 PMC: 11897801. DOI: 10.1002/cnr2.70120.


Repeat TURBT in large volume high-grade non-invasive bladder cancer.

Durant A, Nguyen M, Choudry M, Mi L, Andrews J, Tyson M Bladder Cancer. 2025; 10(4):270-277.

PMID: 40035080 PMC: 11864239. DOI: 10.1177/23523735241303350.


Prediction of recurrence risk in patients with non-muscle-invasive bladder cancer.

Ahmadi N, Shafee H, Moudi E Asian J Urol. 2024; 11(4):625-632.

PMID: 39533991 PMC: 11551389. DOI: 10.1016/j.ajur.2023.04.007.


Prognostic significance of residual tumor at restaging transurethral bladder resection in high-risk non-muscle-invasive bladder cancer.

Guigui A, Basile G, Zattoni F, Gallioli A, Verri P, Aumatell J World J Urol. 2024; 42(1):480.

PMID: 39133324 DOI: 10.1007/s00345-024-05192-x.


Do we need a re-TUR after en bloc resection of T1 stage bladder cancer?.

Levy S, Pericart S, Bajeot A, Fakhfakh S, Lesourd M, Soulie M World J Urol. 2024; 42(1):475.

PMID: 39115589 PMC: 11310258. DOI: 10.1007/s00345-024-05175-y.